CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating activities
Net loss	$ (36,743)	$ (175,544)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,762	8,072
Compensation expense on stock-based arrangements with employees and consultants	10,341	10,880
Changes in operating assets and liabilities:
Accounts receivable	(150,082)	(31,589)
Prepaid expenses and other current assets	6,874	(4,969)
Inventories	(53,342)	121,227
Security deposits	850
Accounts payable	87,663	(37,998)
Sales incentives	(99,128)
Deferred compensation	(51,051)	(19,226)
Accrued liabilities	4,099	(11,912)
Net cash used in operating activities	(271,757)	(141,059)
Investing activities
Capitalized patent costs	(20,192)	(2,575)
Net cash used in investing activities	(20,192)	(2,575)
Financing activities
Cash overdraft	38,449
Proceeds from issuance of notes payable to stockholders	200,000	200,000
Repayments of stockholders loan		(50,000)
Payment of capital lease obligations	(938)	(939)
Net cash provided by financing activities	237,511	149,061
Net (Decrease) / Increase in cash and cash equivalents	(54,438)	5,427
Cash and cash equivalents at beginning of period	54,438	12,806
Cash and cash equivalents at end of period		18,233
Supplemental cash flow information:
Cash paid for interest	61,164	59,074
Cash paid for taxes
Supplemental disclosure of non-cash transactions:
Forgiveness of stockholder loan and accrued interest		$ 26,373